Abstract
Aim
The present study was undertaken to compare the efficacy of isosorbide mononitrate (IMN) and misoprostol for cervical ripening in termination of pregnancy between 8 and 12 weeks.
Materials and methods
This prospective randomized single blind study enrolled 40 women with singleton pregnancy seeking surgical termination of pregnancy between 8 and 12 weeks of gestation. They were divided into two groups—group I received IMN 40 mg while group II received misoprostol 40 mg vaginally, 3 h prior to suction and evacuation. All women were monitored for effects of cervical ripening and adverse effects.
Results
The mean sizes of dilators that could be negotiated without any resistance was 5.9 ± 1.33 in group I and 8.6 ± 0.94 in group II (p < 0.001, 95% CI 0.58, 0.41). The mean dilator sizes at which resistance was first encountered was 6.9 ± 1.37 in group I and 9.9 ± 1.23 in group II (p < 0.001, 95% CI 0.60, 0.54). The mean blood loss was 61.5 ± 13.86 ml in group I and 36.25 ± 12.80 ml in group II (p < 0.001, 95% CI 6.07, 5.63). Headache was the most common adverse effect seen with IMN use.
Conclusion
The results show that IMN has a definite role and better safety profile than misoprostol in first trimester cervical ripening, although misoprostol is more effective and causes less blood loss.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Schulz KF, Grimes DA, Cates W (1983) Measures to prevent cervical injury during suction curettage abortion. Lancet 1:1182–1184
WHO Scientific Group (2003) Cervical preparation. Safe abortion: technical and policy guidance for health systems. World Health Organization, Geneva, p 30
Jonasson A (1984) Laminaria—a modern cervix dilatation method with more than a 100 year history. Jordemodern 97:187–195
Rath W, Osmers R, Adelmann GBC, Stuhisatz HW, Szevereny M, Kuhn W (1993) Biochemical changes in human cervical connective tissue after intracervical application of prostaglandin E2. Prostaglandins 45:375–384
Ashok PW, Flett GM, Templeton A (2000) Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study. Am J Obstet Gynecol 183:998–1002
Chuck FJ, Huffaker BJ (1995) Labor induction with intravaginal misoprostol versus intracervical prostaglandin E2 gel (prepidil gel): a randomized comparison. Am J Obstet Gynecol 173:1137–1142
David M, Chen C (2005) Comparison of isosorbide mononitrate (MonoMack) and misoprostol (Cytotec) for cervical ripening in the first trimester missed abortion. Arch Gynecol Obstet 273:144–145
Troncoso GA, Alvaraob AV, Gomez AB, Francisco J, Herrera M, Zerati RV et al (2005) Intracervical application of the nitric oxide donor isosorbide dinitrate for induction of cervical ripening: a randomized controlled trial to determine clinical efficacy and safety prior to first trimester surgical evacuation of retained products of conception. Br J Obstet Gynecol 112:1615–1619
Radulovic N, Norstrom A, Eherhovd E (2007) Outpatient cervical ripening before first trimester surgical abortion: a comparison between misoprostol and isosorbide mononitrate. Acta Obstet Gynecol Scand 86:344–348
Chen FC, Bergann A, Krosse J, Merholz A, David M (2008) Isosorbide mononitrate vaginal gel versus misoprostol vaginal gel versus Dilapan-S for cervical ripening before first trimester curettage. Eur J Obstet Gynecol Reprod Biol 138(2):176–179
Denguezli W, Trimech A, Haddad A, Hajjaji A, Saidani Z, Faleh R et al (2007) Efficacy and safety of six hourly vaginal misoprostol versus intracervical dinoprostone: a randomized controlled trial. Arch Gynecol Obstet 276(2):119–124
Nicoll AE, Mackenzie F, Greer IA, Norman JE (2001) Vaginal application of the nitric oxide donor isosorbide mononitrate for preinduction cervical ripening: a randomized controlled trial to determine effects on maternal and fetal hemodynamics. Am J Obstet Gynecol 184:558–564
Osman I, Mackenzie F, Norrie J, Murray HM, Greer IA, Norman JE (2006) The “PRIM” study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term. Am J Obstet Gynecol 194:1012–1021
Ivy Li, Chao Carina CW, Ho Chung P (2003) A study of the efficacy of cervical ripening with nitric oxide donor versus placebo for cervical priming before second trimester termination of pregnancy. Contraception 68:269–272
Ekerhovd E, Bullarbo M, Andersch B, Norstrom A (2003) Vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening at term: a randomized controlled study. Am J Obstet Gynecol 189:1692–1697
Ekerhovd E, Weijdegard B, Brannstrom M, Mattsby BI, Norstrom A (2002) Nitric oxide induced cervical ripening in the human; involvement of cyclic guanosine monophosphate, prostaglandin F(2a) and prostaglandin E(2). Am J Obstet Gynecol 186:745–750
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Duhan, N., Gupta, S., Dahiya, K. et al. Comparison of isosorbide mononitrate and misoprostol for cervical ripening in termination of pregnancy between 8 and 12 weeks: a randomized controlled trial. Arch Gynecol Obstet 283, 1245–1248 (2011). https://doi.org/10.1007/s00404-010-1535-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-010-1535-9